摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-4-氟苯乙酮 | 1006-39-9

中文名称
2-溴-4-氟苯乙酮
中文别名
2'-溴-4'-氟苯乙酮
英文名称
1-(2-bromo-4-fluorophenyl)ethanone
英文别名
2-bromo-4-fluoroacetophenone;1-(2-bromo-4-fluorophenyl)ethan-1-one;2'-Bromo-4'-fluoroacetophenone
2-溴-4-氟苯乙酮化学式
CAS
1006-39-9
化学式
C8H6BrFO
mdl
MFCD00077464
分子量
217.037
InChiKey
RCXFSBRMWBFWMH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    48-50°C
  • 沸点:
    150°C 12mm
  • 密度:
    1.535±0.06 g/cm3(Predicted)
  • 闪点:
    110°C
  • 溶解度:
    易溶于可溶于氯仿、甲醇
  • 稳定性/保质期:
    常温常压下稳定,避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36
  • 危险类别码:
    R36/38
  • 海关编码:
    2914700090
  • 危险性防范说明:
    P305+P351+P338
  • 危险性描述:
    H315,H319
  • 储存条件:
    请将容器密封保存,并存放在阴凉、干燥的地方。

SDS

SDS:d85fe8c9a6164cd71be3582bc0e31728
查看
Material Safety Data Sheet

Section 1. Identification of the substance
1-Acetyl-2-bromo-4-fluorobenzene
Product Name:
Synonyms: 2’-Bromo-4’-fluoroacetophenone

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P362: Take off contaminated clothing and wash before reuse
P321: Specific treatment (see on this label)
P332+P313: If skin irritation occurs: Get medical advice/attention
P337+P313: If eye irritation persists get medical advice/attention

Section 3. Composition/information on ingredients.
1-Acetyl-2-bromo-4-fluorobenzene
Ingredient name:
CAS number: 1006-39-9

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H6BrFO
Molecular weight: 217.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    2-溴-4-氟苯乙酮 在 C44H48IrN4(1+)N,N-二异丙基乙胺 作用下, 以 二甲基亚砜N,N-二甲基甲酰胺 为溶剂, 反应 5.0h, 生成 4-氟苯乙酮
    参考文献:
    名称:
    高通量合成和筛选铱(III)芳基溴化物的快速和化学选择性脱卤反应
    摘要:
    一种高通量光学筛选方法,用于1152种阳离子铱(III)配合物([Ir(C ^ N)2(N ^ N)] +)的结构多样的文库的光催化活性,对应于48个环金属化(开发了C 1 N和24个辅助(N N)配体。这种快速测定利用高对比度指示剂染料香豆素6的比色变化来监测从牺牲胺供体到金属络合物激发态的光诱导电子转移。结果[Ir(C ^ N)2(N ^ N)] 0然后可以将芳基溴化物还原以形成高反应性的芳基自由基中间体。该反应的速率由两个配位体的分子结构决定。通过这种方法确定的相对反应速率常数与19密切相关使用氟化底物获得的1 H NMR测量值。一个简单的模型将速率常数表示为分配给72个配体中每一个的“强度”参数的乘积,可以很好地说明1152个测得的速率常数。表现最佳的配合物比光氧化还原转化中常用的基准光催化剂具有更高的反应性。还成功地测试了催化剂的化学选择性。发达的筛选方法可以生成使用现代数据科学提取结构-活动关系所需的大数据集。
    DOI:
    10.1021/acscatal.0c02247
  • 作为产物:
    描述:
    参考文献:
    名称:
    苯乙酮N-甲苯磺酰and与乙烯基的分子内反应:布朗斯台德酸促进阳离子环化成多取代茚
    摘要:
    在存在TsNHNH 2的情况下,开发了布朗斯台德酸促进的邻-(1-芳基乙烯基)苯乙酮衍生物的分子内环化反应,导致多取代的茚并酮具有复杂性和多样性,产率中等至优异。与自由基或卡宾涉及醛基N-甲苯磺酰hydr与乙烯基的环化形成鲜明对比,涉及阳离子环化途径,其中N-甲苯磺酰zone在该转化过程中用作亲电试剂和烷基化试剂。
    DOI:
    10.1039/d0cc07966a
点击查看最新优质反应信息

文献信息

  • AZOLE DERIVATIVE, INTERMEDIATE COMPOUND, METHOD FOR PRODUCING AZOLE DERIVATIVE, AGRICULTURAL OR HORTICULTURAL CHEMICAL AGENT, AND PROTECTIVE AGENT FOR INDUSTRIAL MATERIAL
    申请人:Kureha Corporation
    公开号:US20200288714A1
    公开(公告)日:2020-09-17
    It is provided a plant disease controlling agent having low toxicity to human and animals and excellent handling safety, and showing excellent controlling effects on various plant diseases and high antibiotic action to plant disease germs. A compound represented by the following the general formula (I), or an N-oxide or agrochemically acceptable salt thereof.
    提供一种植物病害控制剂,对人类和动物毒性低,具有出色的操作安全性,在各种植物病害上显示出优秀的控制效果,并对植物病原菌具有高抗生素作用。 由以下一般式(I)表示的化合物,或其N-氧化物或农药可接受的盐。
  • [EN] PIPERAZINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLU5 RECEPTORS<br/>[FR] DÉRIVÉS DE PIPÉRAZINE ET LEUR UTILISATION À TITRE DE MODULATEURS ALLOSTÉRIQUES POSITIFS DES RÉCEPTEURS MGLUR5
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2013087806A1
    公开(公告)日:2013-06-20
    This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description.
    这项发明涉及到式I化合物,它们作为mGlu5受体活性的正向变构调节剂的用途,含有这些化合物的药物组合物,以及将其用作治疗和/或预防与谷氨酸功能障碍相关的神经和精神疾病,如精神分裂症或认知功能下降,如痴呆症或认知障碍的药剂的方法。A、B、Ar、R1、R2、R3在描述中有给定的含义。
  • NOVEL COMPOUNDS
    申请人:RUDOLF Klaus
    公开号:US20130158038A1
    公开(公告)日:2013-06-20
    This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R 1 , R 2 , R 3 have meanings given in the description.
    这项发明涉及到式I的化合物,它们作为mGlu5受体活性的正向变构调节剂的用途,含有这些化合物的药物组合物,以及将其用作治疗和/或预防与谷氨酸功能障碍相关的神经和精神障碍,如精神分裂症或认知功能下降,如痴呆症或认知障碍的药剂的方法。A、B、Ar、R1、R2、R3在描述中有给定的含义。
  • [EN] BENZOFURAN DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS<br/>[FR] DERIVES DE BENZOFURANE UTILISES POUR TRAITER DES TROUBLES HYPERPROLIFERANTS
    申请人:BAYER PHARMACEUTICALS CORP
    公开号:WO2005014566A1
    公开(公告)日:2005-02-17
    The invention relates to novel heterocycles of formula (I), processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.
    这项发明涉及到式(I)的新异环化合物,以及用于制备这些化合物的方法,以及它们用于制备治疗或预防疾病的药物,特别是治疗过度增殖性疾病的药物。
  • PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME
    申请人:Mikoshiba Katsuhiko
    公开号:US20120277423A1
    公开(公告)日:2012-11-01
    The present invention relates to: a ketone compound having transglutaminase-inhibiting activity, which is represented by the following Formula 1, 2, or 3: wherein R 1 is a substituted or unsubstituted aryl or heterocyclyl group, R 2 , R 3 , and R 4 are hydrogen atoms, n is 2, X is halogen, R 5 and R 6 independently represent a hydrogen atom or a substituted or unsubstituted C1-C10 alkyl, aryl, or aralkyl group, wherein R 5 and R 6 are not hydrogen atoms at the same time, or R 5 and R 6 may be taken together to form a saturated or unsaturated and substituted or unsubstituted heterocyclyl group containing a nitrogen atom (N); an inhibitor of protein crosslinking comprising the compound; and a composition for preventing or treating a protein-crosslinking causative disease, which comprises the compound or the protein crosslinking inhibitor.
    本发明涉及:一种具有转谷氨酰胺酶抑制活性的酮化合物,由下式1、2或3表示: 其中R1是取代或未取代的芳基或杂环基团,R2、R3和R4是氢原子,n是2,X是卤素,R5和R6独立地表示氢原子或取代或未取代的C1-C10烷基、芳基或芳烷基团,其中R5和R6不同时为氢原子,或者R5和R6可以共同形成含氮原子(N)的饱和或未饱和的、取代或未取代的杂环基团;包含该化合物的蛋白质交联抑制剂;以及包含该化合物或蛋白质交联抑制剂的用于预防或治疗由蛋白质交联引起的疾病的组合物。
查看更多